Company profile
Elucid
Boston medical technology company whose AI software quantifies coronary and carotid plaque from CT scans to help physicians assess heart-attack and stroke risk without surgery.
- Location
- Boston, MA
- Website
- elucid.com
Latest known funding
Series D round
- Capital
- $55M
- Announced
- Sep 2, 2026